First Device to Treat Migraine With Aura Approved
The Cerena Transcranial Magnetic Stimulator (TMS) is held to the back of the head and the user presses a button to release a pulse of magnetic energy. This stimulates the brain's occipital cortex, which may reduce or eliminate migraine-associated pain, the FDA said in a news release.
The device was tested in a clinical trial of 201 people with mostly moderate-to-strong migraines. Nearly 38 percent of people with migraine pain were pain-free two hours after use, compared with 17 percent of people who didn't use the device, the FDA said. The device was not evaluated among people with headaches other than those with migraines preceded by aura, the agency said.
Among the rare side effects reported were sinusitis and dizziness. The device shouldn't be used by people with metals in the head, neck or upper body, or by people with an implanted medical device such as a pacemaker or deep brain stimulator, the FDA said.
The Cerena TMS is produced by eNeura Therapeutics, based in Sunnyvale, Calif.
More information
The FDA has more about this approval.
'You have to check your entire body' The test represents the latest effort to combat Lyme, the most common tick-borne disease in the United States. NewsdayTV's Ken Buffa spoke with local experts on what you can do to prevent this disease.
'You have to check your entire body' The test represents the latest effort to combat Lyme, the most common tick-borne disease in the United States. NewsdayTV's Ken Buffa spoke with local experts on what you can do to prevent this disease.
